Genetic Signatures FCO/Deuda

¿Qué hace Genetic Signatures? Genetic Signatures Ltd, listed on the Australian Securities Exchange under the ticker GSS.AX, is a company based in Sydney, Australia, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public through an IPO on March 31, 2015. Genetic Signatures Ltd focuses on molecular diagnostics, developing real-time PCR-based products for the detection of infectious diseases. Its principal activities involve research and commercialization of technologies that identify individual genetic signatures to detect diseases, selling associated products in diagnostic and research markets. The company has developed a platform technology called 3base, which enables high-volume hospitals and pathology laboratories to screen for various infectious pathogens with high specificity and rapid throughput. The firm designs and manufactures a suite of real-time PCR-based products under the EasyScreen brand, including the EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, and EasyScreen Viral Meningitis Detection Kit, among others. The company's website is https://geneticsignatures.com/au/. Genetic Signatures es una de las empresas más populares en Eulerpool.